Immunoadjuvant Properties of the Rho Activating Factor CNF1 in Prophylactic and Curative Vaccination against Leishmania infantum
Open Access
- 3 June 2016
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 11 (6) , e0156363
Abstract
There is a need to develop new effective immunoadjuvants for prophylactic or therapeutic vaccines against intracellular pathogens. The activation of Rho GTPases by bacterial cytotoxic necrotizing factor 1 (CNF1) elicits humoral protective responses against protein antigens. Here, we set out to investigate whether CNF1 activity initiates humoral immunity against co-administered parasite antigens and anti-microbial immune signaling. We report that co-administration of wild-type (WT) CNF1 with Leishmania (L.) promastigote antigens at the nasal mucosa triggered prophylactic and curative vaccine responses against this parasite. Vaccination of the mucosa with promastigote lysate antigens combined with WT CNF1 conferred protection against high inoculum L. infantum infection, which reached 82% in the spleen. Immune parameter analysis by antigen recall indicated robust T-helper (Th)1 polarization of immune memory cells, with high IL-2 and IFN-γ production combined with decreased IL-4 production. Additionally, we explored the curative effect of WT CNF1 on previously infected animals. We observed that PL combined with WT CNF1, but not the inactive C866S mutant CNF1 (mCNF1), induced a 58% decrease in the parasite burden in the spleen.Keywords
Funding Information
- Agence Nationale de la Recherche (ANR 11BSV3 004 01)
- Agence Nationale de la Recherche (ANR-11-LABX-0028-01)
- Institut National de la Santé et de la Recherche Médicale (FR)
- Groupe d'action contre la Leishmaniose (GACL)
- Agence Nationale de la Recherche (ANR-10-LABEX-33)
This publication has 27 references indexed in Scilit:
- Escherichia coli α-Hemolysin Counteracts the Anti-Virulence Innate Immune Response Triggered by the Rho GTPase Activating Toxin CNF1 during BacteremiaPLOS Pathogens, 2015
- Effector-triggered versus pattern-triggered immunity: how animals sense pathogensNature Reviews Immunology, 2013
- Pathogen-Derived Effectors Trigger Protective Immunity via Activation of the Rac2 Enzyme and the IMD or Rip Kinase Signaling PathwayImmunity, 2011
- New adjuvants for human vaccinesCurrent Opinion in Immunology, 2010
- Intranasal immunization with tetanus toxoid and CNF1 as a new mucosal adjuvant protects BALB/c mice against lethal challengeVaccine, 2007
- Rho GTPase-activating bacterial toxins: from bacterial virulence regulation to eukaryotic cell biologyFEMS Microbiology Reviews, 2007
- The Rho GTPase activators CNF1 and DNT bacterial toxins have mucosal adjuvant propertiesVaccine, 2004
- Activation and Proteasomal Degradation of Rho GTPases by Cytotoxic Necrotizing Factor-1 Elicit a Controlled Inflammatory ResponseJournal of Biological Chemistry, 2004
- Gln 63 of Rho is deamidated by Escherichia coli cytotoxic necrotizing factor-1Nature, 1997
- Toxin-induced activation of the G protein p21 Rho by deamidation of glutamineNature, 1997